Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Feeney

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Gastro Hep Advances|August 12, 2024
Phase II Feasibility Study of the Efficacy, Tolerability, and Impact on the Gut Microbiome of a Low-Residue (Fiber) Diet in Adult Patients With Mitochondrial DiseaseDavid Houghton, Yi Shiau Ng, Matthew A Jackson, et al.
Scientific Reports|May 18, 2026
Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trialRenae J Stefanetti, Chiara Pizzamiglio, Alasdair P Blain, et al.
The New England Journal of Medicine|July 17, 2025
Mitochondrial Donation and Preimplantation Genetic Testing for mtDNA DiseaseLouise A Hyslop, Emma L Blakely, Magomet Aushev, et al.
Brain : a Journal of Neurology|December 20, 2021
Forecasting stroke-like episodes and outcomes in mitochondrial diseaseYi Shiau Ng, Nichola Z Lax, Alasdair P Blain, et al.
Ebiomedicine|March 7, 2018
MT-ND5 Mutation Exhibits Highly Variable Neurological Manifestations at Low Mutant LoadYi Shiau Ng, Nichola Z Lax, Paul Maddison, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Gastro Hep Advances|August 12, 2024
Phase II Feasibility Study of the Efficacy, Tolerability, and Impact on the Gut Microbiome of a Low-Residue (Fiber) Diet in Adult Patients With Mitochondrial DiseaseDavid Houghton, Yi Shiau Ng, Matthew A Jackson, et al.
Scientific Reports|May 18, 2026
Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trialRenae J Stefanetti, Chiara Pizzamiglio, Alasdair P Blain, et al.
The New England Journal of Medicine|July 17, 2025
Mitochondrial Donation and Preimplantation Genetic Testing for mtDNA DiseaseLouise A Hyslop, Emma L Blakely, Magomet Aushev, et al.
Brain : a Journal of Neurology|December 20, 2021
Forecasting stroke-like episodes and outcomes in mitochondrial diseaseYi Shiau Ng, Nichola Z Lax, Alasdair P Blain, et al.
Ebiomedicine|March 7, 2018
MT-ND5 Mutation Exhibits Highly Variable Neurological Manifestations at Low Mutant LoadYi Shiau Ng, Nichola Z Lax, Paul Maddison, et al.
Pageof 2